Benlysta 400 English


Benlysta is an antibody specifically for the treatment and management of lupus symptoms. This inhibits the proliferation of B-cells, reducing lupus symptoms

Quantity Discount (%) Price
1 - 5 $1,599.00
6 - 10 0.63 % $1,589.00
11 - 20 0.94 % $1,584.00
21+ 1.25 % $1,579.00
SKU: 88858 Category:


Benlysta is an FDA-approved drug that is specifically indicated to treat and manage the symptoms of lupus. This substance is a human monoclonal antibody that is directed against the human BLyS protein so as to affect the survivability of B-cells, which are immune cells that are involved in the production of autoantibodies. Benlysta inhibits the binding of B Lymphocyte Stimulator (BLyS), a protein essential for B-cell survival, to its receptor on B-cells. By doing so, the numbers of B-cell numbers decline, and related disease activity is subsequently lowered.